WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007092496) 7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGS AS HSP90-INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/092496    International Application No.:    PCT/US2007/003252
Publication Date: 16.08.2007 International Filing Date: 05.02.2007
IPC:
A61K 31/522 (2006.01), A61K 31/495 (2006.01), A61K 31/65 (2006.01), A61K 31/7052 (2006.01), A61K 36/24 (2006.01), A61K 38/21 (2006.01), A61K 39/395 (2006.01), A61K 51/00 (2006.01), A61P 35/00 (2006.01), A61P 37/00 (2006.01), A61P 43/00 (2006.01), C07D 473/28 (2006.01)
Applicants: CONFORMA THERAPEUTICS CORPORATION [US/US]; c/o Biogen Idec Inc., 5200 Research Place, San Diego, CA 92122 (US) (For All Designated States Except US).
LE BRAZIDEC, Jean-yves [FR/US]; (US) (For US Only).
KASIBHATLA, Srinivas, Rao [US/US]; (US) (For US Only).
HURST, David [US/US]; (US) (For US Only).
BOEHM, Marcus, F. [US/US]; (US) (For US Only)
Inventors: LE BRAZIDEC, Jean-yves; (US).
KASIBHATLA, Srinivas, Rao; (US).
HURST, David; (US).
BOEHM, Marcus, F.; (US)
Agent: FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, LLP.; 901 New York Avenue, N.W., Washington, D.C., 20001-4413 (US)
Priority Data:
60/771,065 07.02.2006 US
Title (EN) 7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGS AS HSP90-INHIBITORS
(FR) 7,9-DIHYDRO-PURIN-8-ONE ET ANALOGUES ASSOCIÉS UTILISÉS EN TANT QU'INHIBITEURS DE HSP90
Abstract: front page image
(EN)The invention relates in general to 7,9-dihydro-purin-8-one and related compounds that show broad utility, e.g., in inhibiting heat shock protein 90 (HSP90) to thereby treat or prevent HSP90-mediated diseases.
(FR)L'invention concerne, de manière générale, du 7,9-dihydro-purin-8-one et des composés associés présentant une grande utilité, par exemple, dans l'inhibition de la protéine 90 de choc thermique (HSP90), en vue de traiter ou prévenir des maladies induites par HSP90.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)